The Effect of the Lacticaseibacillus paracasei BEPC22 and Lactiplantibacillus plantarum BELP53 Combination (BN-202M) on Body Fat Percentage Loss in Overweight Individuals: A Randomized, Double-Blind, Placebo-Controlled Study
Nutrients · 2024
DOI: 10.3390/nu16131993 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Han-Seul Kwon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Korean Obstetrics and Gynecology, College of Korean Medicine, Semyung University, Jecheon 27136, Republic of Korea. Hauptthemen laut MEDLINE: Overweight, Probiotics, Adipose Tissue. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy (MOTIE) and the Korea Evaluation Institute of Industrial Technology (KEIT) through the Research and Development Project….
Abstract (Originalsprache)
BN-202M is derived from humans and consists of two strains, Lacticaseibacillus paracasei BEPC22 and Lactiplantibacillus plantarum BELP53. Body fat reduction effect and safety of BN-202M were assessed in overweight participants. A total of 150 participants were randomly assigned to the BN-202M and placebo groups at a 1:1 ratio. Dual-energy X-ray absorptiometry was used to objectively measure body fat. After 12 weeks of oral administration, the body fat percentage (−0.10 ± 1.32% vs. 0.48 ± 1.10%; p = 0.009) and body fat mass (−0.24 ± 1.19 kg vs. 0.23 ± 1.05 kg; p = 0.023) of the BN-202M group decreased significantly compared to those of the placebo group. The body weight (−0.58 kg, p = 0.004) and body mass index (BMI; −0.23, p = 0.003) was found to decrease significantly at 12 weeks in the BN-202M group, but not in the placebo group. Metabolome analysis revealed that β-alanine, 3-aminoisobutyric acid, glutamic acid, and octopamine decreased in the weight-decreased BN-202M post-intake group. In the gut microbiota analysis, Akkermansia showed a statistically significant increase in the BN-202M group post-intake compared to the placebo group. No serious adverse events were observed in either group. These results suggest that BN-202M is safe and effective for reducing body fat and weight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Korean Obstetrics and Gynecology, College of Korean Medicine, Semyung University, Jecheon 27136, Republic of Korea.
- R&D Center, Hecto Healthcare Co., Ltd., Seoul 06142, Republic of Korea.
- Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea.
- Research Institute for Bioactive-Metabolome Network, Konkuk University, Seoul 05029, Republic of Korea.
ORCID-Profile: Han-Seul Kwon, Kum-Joo Shin, Na-Rae Lee, Hyeong-Jun Kim
Förderung
- Ministry of Trade, Industry and Energy (MOTIE) and the Korea Evaluation Institute of Industrial Technology (KEIT) through the Research and Development Project…
Zitieren
APA
Kwon, H. S., Kim, S. J., Shin, K. J., Kim, S., Yun, J., Bae, J., Tak, H. J., Lee, N. R., & Kim, H. J. (2024). The Effect of the Lacticaseibacillus paracasei BEPC22 and Lactiplantibacillus plantarum BELP53 Combination (BN-202M) on Body Fat Percentage Loss in Overweight Individuals: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. https://doi.org/10.3390/nu16131993
Vancouver
Kwon HS, Kim SJ, Shin KJ, Kim S, Yun J, Bae J, et al. The Effect of the Lacticaseibacillus paracasei BEPC22 and Lactiplantibacillus plantarum BELP53 Combination (BN-202M) on Body Fat Percentage Loss in Overweight Individuals: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. 2024. doi:10.3390/nu16131993
BibTeX
@article{Kwon2024,
author = {Kwon, Han-Seul and Kim, Seok-Jin and Shin, Kum-Joo and Kim, Sanghoon and Yun, Jongbok and Bae, Jaewoong and Tak, Hyun-Ji and Lee, Na-Rae and Kim, Hyeong-Jun},
title = {The Effect of the Lacticaseibacillus paracasei BEPC22 and Lactiplantibacillus plantarum BELP53 Combination (BN-202M) on Body Fat Percentage Loss in Overweight Individuals: A Randomized, Double-Blind, Placebo-Controlled Study},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16131993}
}
EUVIMED